This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Identification and characterization of the in-vivo metabolites of the novel soluble epoxide hydrolase inhibitor EC5026 using liquid chromatography quadrupole time of flight mass spectrometry, Journal of Pharmaceutical and Biomedical Analysis, July 2024, Elsevier,
DOI: 10.1016/j.jpba.2024.116116.
You can read the full text:
The following have contributed to this page
